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Dr. Reiter acknowledges the sensitivity of
malaria to climatic influences, and I am sure that
he agrees that change in climate will affect risk
for transmission—he may be skeptical as to
whether global warming will ever become a fact,
but that is another question. While Reiter’s paper
offers an interesting perspective on the history of
malaria in Europe, it provides no illuminating
information on the influence of climate change on
human health.
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For P. Reiter’s response, please see
http://www.cdc.gov/ncidod/EID/vol6no4/reiter.htm
Serologic Evidence of Human Monocytic
and Granulocytic Ehrlichiosis in Israel
To the Editor: : : : : We read with great attention the
article by Dr. Keysary et al., who reported the
first evidence of human monocytic and granulo-
cytic ehrlichiosis in Israel (1); however, we
disagree with their conclusions.
Ehrlichiae comprise a large group of
intracellular organisms pathogenic for animals
and occasionally for humans. Because these
organisms are closely related, serologic cross-
reactions occur within and between groups,
leading to mistakes in identification. For
example,  Ehrlichia chaffeensis was misdiag-
nosed as E. canis in humans (2) and human
granulocytic ehrlichiosis as human monocytic
ehrlichiosis in areas where the vector was not
present (3). Because of such cross-reactions,
serology alone is not sufficient to establish the
existence of a new ehrlichial disease.
With the exception of Rhipicephalus
sanguineus, the brown dog tick, which is
distributed worldwide, tick species of medical
importance are very geographically specific. For
example, the Ixodes and Dermacentor spp. found
in Europe are not those found in the United
States. Consequently, tick-transmitted organ-
isms and diseases are also very specific
geographically. For example, Borrelia spp. found
in the Old World are not found in America (except
for B. burgdorferi stricto sensu, which is found in
both Europe and America). R. rickettsii,
transmitted by Dermacentor andersoni and
D. variablilis, is reported in the United States but
not in Europe, where the vectors are not present.
American monocytic ehrlichiosis is caused by
E. chaffeensis, which is transmitted by the tick
Amblyomma americanum, found only in America.
The main reservoir is the deer Odocoileus
virginanus (4).
It is very unlikely that a tick-borne disease
occurred in a country where neither the vector
nor the reservoir of the bacterium exists. All
attempts to demonstrate the presence of
E. chaffeensis in the Old World, including Africa,
have failed. Indeed, there is no convincing
evidence of the existence of E. chaffeensis outside
America.
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